HBsAg as predictor of outcome in renal transplant patients

Medicina

Volumn 64, Issue 5, 2004, Pages 429-432

  Ridruejo, Ezequiel ^a,c   del Rosario Brunet, Maria ^b   Cusumano, Ana ^b   Diaz, Carlos ^b   Davalos Michel, Mario ^b   Jost, Luis ^b   Mando, Oscar G ^a   Vilches, Antonio ^b  

^a Departamento de Medicina   (Argentina)

^b Departamento de Medicina   (Argentina)

^c NONE   (Argentina)

Author keywords

Chronic viral hepatitis; Outcome; Renal transplantation

Indexed keywords

ALANINE AMINOTRANSFERASE; AZATHIOPRINE; CYCLOSPORIN; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; METHYLPREDNISOLONE; THYMOCYTE ANTIBODY; VIRUS ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; AGE; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; FEMALE; GENDER; GRAFT FAILURE; GRAFT SURVIVAL; HEPATITIS B; HEPATITIS C; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PREOPERATIVE EVALUATION; PREVALENCE; RETROSPECTIVE STUDY; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; SURVIVAL RATE;

ADULT; AGE FACTORS; ARGENTINA; EPIDEMIOLOGIC METHODS; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HEPATITIS ANTIBODIES; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; TIME FACTORS;

EID: 9744258835     PISSN: 00257680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Camps DH, Azcona S, Bertola S, et al. Prevalencia de anticuerpos anti-hepatitis por virus C en hemodializados crónicos. Medicina (Buenos Aires) 1992; 52: 511-5.
2. Pereira BJG, Levey AS. Hepatitis C virus infection in dialysis and renal transplantation. Kidney Int 1997; 51: 981-99.
3. Vosnides G. Hepatitis C in renal transplantation. Kidney Int 1997; 52: 843-61.
4. Morales J. Renal transplantation in patients positive for hepatitis B or C (pro). Transplant Proc 1998; 30: 2064-9.
5. Pereira BJG. Renal transplantation in patients positive for hepatitis B or C (con). Transplant Proc 1998; 30: 2070-2.
6. Chan TM, Lok ASF, Cheng IKP, Chan R. A prospective study of hepatitis C virus infection among renal transplant recipients. Gastroenterology 1993; 104: 863-8.
7. Boletis J, Delladetisma J, Psimenou E, et al. Liver biopsy is essential in antiHCV(+) renal transplant patients irrespective of liver function tests and serology for HCV. Transplant Proc 1995; 27: 945-7.
8. Aroldi A, Lampertico A, Elli A, et al. Long term evolution of antiHCV positive renal transplant recipients. Transplant Proc 1998; 30: 2076-8.
9. Mathurin P, Mouquet C, Poynard T, et al. Impact of hepatitis B and C virus on kidney transplantation outcome. Hepatology 1999; 29: 263-75.
10. Kim YG, Kim S, Lee JH, et al. Renal transplantation in hepatitis B surface antigen positive patients: single center experience in Korea. Transplant Proc 1994; 26: 2143-5.
11. Wang SW, Lee SW, Choi KH, et al. Clinical outcome of HBsAg(+) renal allograft recipients. Transplant Proc 1996; 28: 1653-4.
12. Durlik M, Gaciong Z, Soluch L, et al. Results of kidney transplantation in HBsAg and antiHCV seropositive renal allograft recipients. Transplant Proc 1996; 28: 3459-60.
13. Mas V, Alvarellos T, Chiurchiu C, et al. Hepatitis C virus infection after renal transplantation: viral load and outcome. Transplant Proc 2001; 33: 1791-3.
14. Durlik M, Gaciong Z, Soluch L, et al. Effect of chronic liver disease (CLD) on clinical outcome in renal allograft recipients. Transplant Proc 1997; 29: 787-90.
15. Pouteil-Noble C, Maiza H, Donia A, et al. Comparison of isolated infection by hepatitis C(HCV) or by hepatitis B(HBV) viruses and of coinfection by HCV-HBV in 1098 renal transplant patients. Transplant Proc 1997; 29: 791-2.
16. Gentil MA, Rocha JL, Rodríguez-Algarra G, et al. Impaired kidney transplant survival in patients with antibodies to hepatitis C virus. Nephrol Dial Transplant 1999; 14: 2455-60.
17. Moscón g, Scolari MP, Morelli C, et al. Renal transplantation and HCV hepatitis: a longitudinal study. Transplant Proc 2001; 33: 1185.
18. Kode RK, Foster CE, Kumar AMS, et al. Nine year experience with kidney transplantation in patients with positive hepatitis C virus antibody. Transplant Proc 2001; 33: 1186-7.
19. Meier-Kriesche HU, Akinolu OO, Hanson JA, et al. Hepatitis C antibody status and outcome in renal transplant recipients. Transplantation 2001; 72: 241-4.
20. Lee WC, Shu KH, Cheng CH, et al. Long term impact of hepatitis B, C virus infection on renal transplantation. Am J Nephrol 2001; 21: 300-6.
21. Port FK, Wolf RA, Mauger EA, et al. Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients. JAMA 1993; 270: 1339-43.
22. Pereira BJ, Svetlozar NN, Bouthot BA, et al. Effect of hepatitis C infection and renal transplantation on survival in end-stage renal disease. Kidney Int 1998; 53: 1374-81.
23. Knoll GA, Tankersley MR, Lee JY, et al. The impact of renal transplantation on survival of hepatitis C positive end-stage renal disease patients. Am J Kidney Dis 1997; 29: 608-14.